Literature DB >> 18435767

Diagnostic performance of clinical motor and non-motor tests of Parkinson disease: a matched case-control study.

N I Bohnen1, S A Studenski, G M Constantine, R Y Moore.   

Abstract

BACKGROUND AND
PURPOSE: The diagnosis of Parkinson disease (PD) is made typically on the basis of motor abnormalities. PD is now recognized to have both motor and non-motor manifestations, indicating a need for the development of reliable non-motor diagnostic tests for PD. The aim of the present study was to compare the accuracy of various clinical motor and non-motor tests for the diagnosis of PD.
METHODS: Forty-five PD patients (Hoehn and Yahr stages 1-3; mean age 59.5 +/- 10.0 years) and 45 healthy controls matched for gender and age completed a clinimetric motor test battery to assess limb bradykinesia, tremor and balance. Non-motor tests consisted of depression, anxiety and smell identification ratings. Area under the receiver operator characteristic curve (AUC) analysis was used.
RESULTS: We found that smell identification was the most accurate predictor of the presence of PD within the overall group of patients and matched control subjects (AUC = 0.886) and also in the subgroups of mild severity (Hoehn and Yahr stages 1-1.5; AUC = 0.923), young-onset (AUC = 0.888) and female PD patients (AUC = 0.797). The second best diagnostic test was the grooved pegboard test for the clinically most affected body side.
CONCLUSIONS: We conclude that olfactory function is the most accurate diagnostic predictor within a heterogeneous sample of patients with PD.

Entities:  

Mesh:

Year:  2008        PMID: 18435767     DOI: 10.1111/j.1468-1331.2008.02148.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  20 in total

1.  Prevalence of impaired odor identification in Parkinson disease with imaging evidence of nigrostriatal denervation.

Authors:  Jacob Haugen; Martijn L T M Müller; Vikas Kotagal; Roger L Albin; Robert A Koeppe; Peter J H Scott; Kirk A Frey; Nicolaas I Bohnen
Journal:  J Neural Transm (Vienna)       Date:  2016-02-24       Impact factor: 3.575

2.  Cranial nerve I: olfaction.

Authors:  Richard D Sanders; Paulette Marie Gillig
Journal:  Psychiatry (Edgmont)       Date:  2009-07

3.  Paradoxical effect of dopamine medication on cognition in Parkinson's disease: relationship to side of motor onset.

Authors:  Brenda Hanna-Pladdy; Rajesh Pahwa; Kelly E Lyons
Journal:  J Int Neuropsychol Soc       Date:  2015-04-29       Impact factor: 2.892

Review 4.  Non-motor features of Parkinson disease.

Authors:  Anthony H V Schapira; K Ray Chaudhuri; Peter Jenner
Journal:  Nat Rev Neurosci       Date:  2017-06-08       Impact factor: 34.870

5.  Ancillary investigations to diagnose parkinsonism: a prospective clinical study.

Authors:  M B Aerts; R A J Esselink; W F Abdo; F J A Meijer; G Drost; N Norgren; M J R Janssen; G F Borm; B R Bloem; M M Verbeek
Journal:  J Neurol       Date:  2014-11-09       Impact factor: 4.849

Review 6.  Olfaction in Parkinson's disease and related disorders.

Authors:  Richard L Doty
Journal:  Neurobiol Dis       Date:  2011-12-20       Impact factor: 5.996

7.  Persistent deficits in heart rate response habituation following neonatal binge ethanol exposure.

Authors:  Katherine C Morasch; Pamela S Hunt
Journal:  Alcohol Clin Exp Res       Date:  2009-06-10       Impact factor: 3.455

Review 8.  Olfactory dysfunction in Parkinson disease.

Authors:  Richard L Doty
Journal:  Nat Rev Neurol       Date:  2012-05-15       Impact factor: 42.937

Review 9.  Hyposmia: a possible biomarker of Parkinson's disease.

Authors:  Qian Xiao; Sheng Chen; Weidong Le
Journal:  Neurosci Bull       Date:  2013-10-17       Impact factor: 5.203

10.  Odor identification and cognitive function in the Beaver Dam Offspring Study.

Authors:  Carla R Schubert; Karen J Cruickshanks; Mary E Fischer; Guan-Hua Huang; Ronald Klein; Nathan Pankratz; Wenjun Zhong; David M Nondahl
Journal:  J Clin Exp Neuropsychol       Date:  2013-06-21       Impact factor: 2.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.